EARLY STAGE INVESTMENT IN CBD AND MEDICINAL CANNABIS BUILDS MOMENTUM WITH FIRST ACQUISITION AGREEMENT
Read moreEARLY STAGE INVESTMENT IN CBD AND MEDICINAL CANNABIS BUILDS MOMENTUM WITH FIRST ACQUISITION AGREEMENT
Read moreCOMPANY ESTABLISHES A STRATEGIC POSITION TO BENEFIT AS FAST-GROWING UK AND EUROPEAN MARKETS EMBRACE CBD AND MEDICINAL CANNABIS
Read moreNetwork Speed Up Over 16% Just Weeks After Previous Benchmarks
Read moreNew Open Initiative Allows Publishers, Journalists and News Organizations to Identify their Original Work Across all Distribution Channels
Read morePressland Prepares for Alpha Launch with Prospective Clients and Partners
Read moreCODE CANNABIS INVESTMENTS SIGNS DEFINITIVE AGREEMENT, ESTABLISHING FOOTHOLD IN LUCRATIVE HEMP CBD MARKET FORECASTED TO REACH $16 BILLION IN REVENUE BY 2025
Read moreLatest Collaboration Strengthens Pressland’s Commitment to Restoring Trust in Media and Protecting User Privacy
Read moreFORMER SUPREME CANNABIS COMPANY AND FSD PHARMA MANAGEMENT TO LEAD GROWTH AND DEVELOPMENT OF EARLY STAGE INVESTMENT PORTFOLIO
Read moreDuignan-Cabrera to leverage proven industry expertise in driving revenue for media and technology companies
Read more